Literature DB >> 1314694

Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma.

E Tsuchiya1, Y Nakamura, S Y Weng, K Nakagawa, S Tsuchiya, H Sugano, T Kitagawa.   

Abstract

We examined loss of heterozygosity (LOH) on all autosomal chromosomes in 53 non-small cell lung carcinomas. Frequent LOH was observed on the long arms of chromosomes 1 (37%), 2 (31%), 5 (30%), 8 (31%), and 13 (32%), and the short arms of chromosomes 3 (54%) and 17 (62%). LOH on chromosomes 3p and 17p was observed in all informative cases of squamous cell carcinoma, but was significantly less frequent in adenocarcinomas (P = 0.003 and 0.001, respectively). Similarly, LOH on chromosome 13q was observed frequently in squamous cell carcinomas (5 of 9 informative cases, or 56%), but in only 5 of 26, or 19%, of adenocarcinomas. In contrast, LOH on chromosome 2q was observed only in adenocarcinomas. In addition, this chromosomal arm was lost more frequently in poorly differentiated, compared to well differentiated adenocarcinomas. Furthermore, a correlation between fractional allelic loss and pathohistological grade was identified. These results implicate the presence of several tumor suppressor genes associated with development and/or progression of non-small cell lung carcinomas.

Entities:  

Mesh:

Year:  1992        PMID: 1314694

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling.

Authors:  K Lin; S Wang; M A Julius; J Kitajewski; M Moos; F P Luyten
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.

Authors:  T Hashimoto; Y Tokuchi; M Hayashi; Y Kobayashi; K Nishida; S Hayashi; Y Ishikawa; K Nakagawa; J Hayashi; E Tsuchiya
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Characterization of four VNTR loci on human chromosome 6.

Authors:  S Takiguchi; S Saito; Y Nakamura
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

4.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.

Authors:  R Mei; P C Galipeau; C Prass; A Berno; G Ghandour; N Patil; R K Wolff; M S Chee; B J Reid; D J Lockhart
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

5.  Abrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis.

Authors:  V C L Wong; J M Y Ko; R Z Qi; P J Li; L D Wang; J-L Li; Y P Chan; K W Chan; E J Stanbridge; M L Lung
Journal:  Br J Cancer       Date:  2011-02-15       Impact factor: 7.640

6.  Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes.

Authors:  R W Wiseman; C Cochran; W Dietrich; E S Lander; P Söderkvist
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs.

Authors:  E Tsuchiya; R Furuta; N Wada; K Nakagawa; Y Ishikawa; B Kawabuchi; Y Nakamura; H Sugano
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 8.  The adenomatous polyposis coli gene and human cancers.

Authors:  Y Nakamura
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas.

Authors:  S Ogasawara; C Maesawa; G Tamura; R Satodate
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.

Authors:  W F Dietrich; E H Radany; J S Smith; J M Bishop; D Hanahan; E S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.